Korean J Pathol.  2013 Oct;47(5):405-410.

Cytotechnologists and On-Site Evaluation of Adequacy

Affiliations
  • 1Department of Pathology, University of Maryland, Baltimore, MD, USA.
  • 2Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. molson8@jhmi.edu
  • 3Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Abstract

While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.

Keyword

Biopsy, fine needle aspiration; Rapid on-site evaluation; On-site evaluation of adequacy; Cytotechnology; Telepathology; Telecytology

MeSH Terms

Biopsy
Biopsy, Fine-Needle
Humans
Telepathology
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr